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New Findings
 What is the central question of this study?
There is an ethical imperative to optimize analgesia protocols for laboratory animals, but
this is impeded by our inability to recognize pain reliably. We examined whether the Mouse
Grimace Scale (MGS) provides benefits over a standard welfare scoring system for identifying
a low level of pain in the frequently used murine surgical model of myocardial infarction.
 What is the main finding and its importance?
Low-level pain, responsive to analgesia, was detected by MGS but not standard methods.
In this model, most of the pain is attributable to the thoracotomy, excepted in mice with
very large infarcts. This approach represents a model for assessing postsurgical analgesia in
rodents.
The Mouse Grimace Scale (MGS) was developed for assessing pain severity, but the general
applicability to complex postsurgical pain has not been established. We sought to determine
whether the MGS provides benefits over and above a standard welfare scoring system for
identifying pain in mice following experimental myocardial infarction. Female C57BL/6J mice
(n = 60), anaesthetized with isoflurane, were subjected to thoracotomy with ligation of a
coronary artery or sham procedure. A single s.c. dose of buprenorphine (1.1 mg kg−1) was
given at the time of surgery and pain assessed at 24 h by MGS and a procedure-specific welfare
scoring system. In some animals, a second dose of 0.6 mg kg−1 buprenorphine was given and
pain assessment repeated after 30 min. The MGS was scored from multiple photographs by
two independent blinded observers with good correlation (r = 0.98). Using the average MGS
score of both observers, we identified a subset of mice with low scores that were not considered
to be in pain by the welfare scoring system or by single observer MGS. These mice showed a
significant improvement with additional analgesia, suggesting that this low-level pain is real.
Pain attributable to the myocardial injury, as opposed to thoracotomy, persisted at 24 h only in
mice with large infarcts >40%. In conclusion, the use of a multi-observer, post hoc version of
the MGS is a sensitive tool to assess the efficacy of postsurgical analgesic protocols. Following
surgical induction of myocardial infarction, we identified a significant proportion of mice that
were in low-level pain at 24 h that were not identified by other assessment methods.
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Introduction
Effective pain management in laboratory rodents is
crucial not only for ethical and legal considerations but
also in order to achieve high-quality science free from
the confounding pathophysiological consequences of
pain (Carbone, 2011). The development of the ARRIVE
guidelines (Kilkenny et al. 2010), the refinement of
pre-existing guidelines (e.g. Guide for the Care and Use of
LaboratoryAnimals, 8th edn, published by theUSNational
Academy of Sciences, Institute for Laboratory Animal
Research, 2011; Carbone, 2012) and the implementation
of new directives (e.g. European Directive 2010/63/EU
on the protection of animals used for scientific purposes)
have all further emphasized the importance of the ‘3Rs’
(replacement, reduction and refinement) in biomedical
research.
Surgical ligation of a major coronary artery in the
mouse is a widely used model of experimental myocardial
infarction (MI) and consequent congestive heart failure.
Despite the fact that thoracotomy is considered one of
the most painful surgical procedures in humans (Gerner,
2008) and that pain from myocardial infarction may be
‘severe and persistent’ (Alderman, 1974), the extent to
which postoperative analgesia is provided for mice is
highly variable and often goes unreported in the published
literature (Patten et al. 1998; Salto-Tellez et al. 2004; Karas,
2006). Of particular concern is the ability of mice, as a
prey species, to adapt and mask pain-related behaviours
(Roughan& Flecknell, 2001), which is likely to result in an
underestimation of pain following this type of procedure.
Amajor problem for treating pain effectively in laboratory
animals is therefore the ability to recognize pain reliably.
The current ‘gold-standard’ approach is to combine
assessment of behavioural and physiological parameters
in specifically designed score sheets; however, these are
often considered time consuming and highly subjective by
animal care staff (Hawkins, 2002). Recently, a newmethod
to evaluate animal pain based on facial expression, the
Mouse Grimace Scale (MGS), was described and validated
in several experimental models of inflicted pain. It was
considered best suited to assess pain which lasted up to
48 h (Matsumiya et al. 2012) and compared favourably
with extensive and complex manual and automatic
behavioural analysis (Leach et al. 2012). However, the
MGS has never been compared with a more standard
pain-scoring scheme, such as those most frequently used
in animal research facilities. Furthermore, its utility to
assess complex surgical pain of longer duration needs to
be assessed.
Therefore, the aims of this study were as follows:
(i) to validate the Mouse Grimace Scale in evaluating
pain 24 h following MI in mice; (ii) to assess how the
MGS compares with a more traditional welfare score
sheet specifically designed for MI; and (iii) to assess the
efficacy of buprenorphine in treating pain induced by the
MI procedure in order to optimize postsurgical analgesic
protocols.
Methods
Ethical approval
All experiments were approved by the institutional ethical
reviewcommitteeof theUniversity ofOxford andconform
with the UK Home Office Guidance on the Operation
of the Animals (Scientific Procedures) Act, 1986 incor-
porating EuropeanDirective 2010/63/EU (licence number
30/2754). No mice underwent surgery for the purposes of
this study. Allmicewere part of an on-going separate study
of chronic heart failure, which required them to be kept
for 8 weeks following myocardial infarction. Any mouse
showing signs of distress, particularly dyspnoea, weight
loss or decreased activity, was killed immediately as a
humane end-point by cervical dislocation. As determined
by theneedsof the separate study, animalswerekilled at the
end of the 8 week experiment by exsanguination under an
overdose of inhaled anaesthetic agent (5% isoflurane). No
untreated control animals were used, i.e. all mice received
our standard practice of at least one dose of long-acting
perisurgical analgesia.
Animal husbandry
Mice were either C57BL/6J obtained from Harlan UK
or were transgenic mice bred in-house overexpressing
creatine transporter in theheartwith a genetic background
congenic to C57BL/6J (as described by Wallis et al.
2005). Transgene expression in this model is restricted
to cardiomyocytes and is therefore highly unlikely to
influence pain perception. Mice were socially housed
(two to five animals per cage) in a specific pathogen-free
environment, with controlled humidity and temperature
(20–22 °C) and a 12 h–12 h light–dark cycle. All mice were
adult females with body weight at time of surgery 22± 2 g
(i.e. approximately 3–4 months old).
Mouse groups
Four groups of mice were studied. There were two
surgical groups; one group was subjected to thoracotomy
with ligation of a coronary artery to induce myocardial
infarction (MI group), and a second group received
thoracotomyonly (shamgroup). Twonon-surgical groups
were used as additional controls; the first received identical
general anaesthesia (GA) using isoflurane as part of a
magnetic resonance imaging (MRI) examination but did
not undergo any surgical procedures (GAonly group), and
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Table 1. Traditional welfare scoring system based on behavioural, clinical and procedure-specific criteria
Observation from a distance (for 5 min)
(1) Inactive
(2) Isolated
(3) Hunched posture
(4) Huddled
(5) Restless
(6) Reluctance to move
(7) Laboured gait/tip-toe walking
(8) Abnormal interaction with congeners (other than isolation; specify)
(9) Excessive attention to surgical site
Observation following cage lid opening
Reaction at cage opening:
(10) Little, no response (not inquisitive, nor alert)
(11) Hyperactive
(12) Starey coat/piloerection
(13) Not grooming
(14) Twitching/tremors
(15) Type of breathing: normal (N), laboured (L; slow, involving the diaphragm but with closed mouth),
open-mouth breathing (O), noisy breathing (crackles; C).
Observation following handling
Reaction to handling:
(16) Reacts violently (attempt to bite, irritation)
(17) Vocalization
(18) Fear (faeces, urine)
(19) Dehydration (skin pinch test/saggy skin)
(20) Discharge from nares/eyes
(21) Wound abnormalities (specify: e.g. inflammation, opened . . . )
(22) Skin/mucosa colour: normal (N), pale (P), cyanosis (C)
(23) Exploring on top of the platform?
Marking scale
∗ for all criteria but breathing and skin/mucous membrane colour:
• Absent criterion: 0
• Doubtful or mildly present: 1
• Present: 2
∗ for type of breathing
• Normal (N): 0
• Moderately laboured: 1
• Laboured (L): 2
• Open-mouth breathing/noisy breathing: 4
∗ for skin/mucosa colour
• Normal (N): 0
• Pale (P): 2
• Cyanosis (C): 4
Total mark out of 50
Mice were assessed first from a distance, then following opening of the cage, before finally being handled.
the last group consisted in mice not under any protocol
(stock control group).
Myocardial infarction surgery
All surgeries were performed in the morning. Permanent
coronary artery ligation was performed by the same
person, as previously described in detail (Lygate, 2006;
Lygate & Neubauer, 2006). In brief, general anaesthesia
was induced with 4% isoflurane, then maintained at 2%
in 100% O2. Mice received 0.024 mg buprenorphine
S.C. (i.e. average dose, 1.1 mg kg−1; Vetergesic, Alstoe
Animal Health, UK), intubated and ventilated with a tidal
volume of 250 µl and respiratory rate 150 breaths min−1
(Hugo-SachsMiniVent type 845; Harvard Apparatus Ltd.,
Kent, UK). A left thoracotomy was performed in the
fourth intercostal space, the pericardium removed, and
an intramyocardial ligature placed 1–2 mm below the
C© 2014 The Authors. Experimental Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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atrioventricular groove using a 6–0 polyethylene suture
(Ethicon, Johnson & Johnson Medical Ltd., Wokingham,
UK). Another group of shammice underwent an identical
protocol without ligation of the coronary artery. Mice
were providedwith supplemental heat overnight, and pain
scoring was performed the following morning, i.e. 24 h
after surgery and initial buprenorphine analgesia.
Traditional behavioural and clinical pain scoring
All mice were scored using a traditional welfare scoring
system (Table 1). This system has been created by
combining criteria frequently used to assess pain or
discomfort in laboratory rodents (Morton, 1999;Hawkins,
2002;Wolfensohn&Lloyd, 2003).Only criteria considered
relevant for the model assessed were used, and the scoring
system was tested and optimized prior to the start of this
study. Assessment was performed in the following three
steps: by observing mice from a distance, at cage opening
and at handling. Each criterion was marked as absent
(0), mildly present or doubtful (1) or present (2). The
importance of breathing and mucous membrane colour
was emphasizedbydoubling thevalue for these criteriadue
to the nature of the surgery performed. All mice received
a mark out of 50.
Mouse Grimace Scale
Mice were placed on an elevated platform (dimensions,
9.5 cm × 6.2 cm, height 36.4 cm) and acclimated for
5 min before photographs were taken over a period of
15–20 min. This confined mice to a small area, without
restraint, and in an open position to ensure good quality
photographs. Photographs were selected for quality a
posteriori to obtain three left and three right profile shots
and four frontal shots. Photographs were cropped to
include the head only and assigned a random number
using a home-written Bash script. All photographs were
scored by two independent observers blinded to mouse
identity using the criteria described in the initial MGS
paper and manual (Langford et al. 2010). The five criteria
(orbital tightening, nose bulge, cheek bulge, ear position
and whisker changes) were assessed, and a score of 0 was
given if the criterion was absent, 1 if moderately present
and 2 if obviously present.
Analgesia
All mice scoring greater than 3/50 on the welfare scoring
system were defined as ‘in pain’ and received an extra
dose of 0.012 mg of buprenorphine S.C. [average dose,
0.6 mg kg−1 (SD, 0.1)]. Mice with a score<3 were defined
as ‘not inpain’, and a randomset of thesemice also received
buprenorphine. Pain was reassessed after 30 min by the
same observer using both systems.
Infarct size
Infarct sizesweremeasuredusing in vivoMRIaspreviously
described (Schneider et al. 2006). Briefly, 8 weeks after
surgery, cine-MRI data were acquired using a 9.4 T MR
system (Agilent Technologies, Santa Clara, CA, USA).
Infarct size was measured with ImageJ (version 1.44o;
National Institutes of Health, Bethesda, MD, USA) as a
percentage of the entire left ventricle.
Statistical analysis
All data were analysed using GraphPad Prism version 5.0
(GraphPad Software, Inc., La Jolla, CA, USA).
Type II regression analysis using Deming’s method was
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Figure 1. Interobserver comparison for pain assessment using the Mouse Grimace Scale (MGS) at 24 h
postsurgery (n = 60 mice before administration of a second dose of buprenorphine)
A shows very good correlation between observers (Deming’s regression). However, Bland–Altman analysis
(B) indicates systematic bias, for one observer versus the other, particularly at the upper range of MGS
scores. Continuous horizontal line represents the mean difference (n = 60).
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performed to correlate interobserver variability of the
MGS. A Wilcoxon matched pairs signed rank test was
used for comparison before and after analgesia. A
Kruskal–Wallis test with Dunn’s post hoc test was used
to assess the effect of the procedure and infarct size
on MGS score. All results were considered significant
when P < 0.05. The MGS data were used in two ways:
(i) taking the mean of two observers; or (ii) the mode
of the observers’ scores to represent a typical ‘bedside’
assessment. Unless otherwise stated, data are expressed as
means ± SD.
Results
Interobserver variability
There was an excellent correlation between the two
observers for MGS measurement (r = 0.98; Fig. 1A).
However, the slope differed from unity, as illustrated by
Bland–Altman analysis, which showed a systematic bias
for higher MGS scores in one of the observers (Fig. 1B).
Comparison of MGS with traditional scoring systems
There was poor correlation between MGS score and body
weight loss at 24 h after surgery (r= 0.48, data not shown).
However, there appeared to be a link between the
traditional welfare scoring system and average MGS score
in all surgical mice (Fig. 2), especially in mice showing
obvious levels of pain and scoring high in both the welfare
system and the MGS. An important consideration is
whether the MGS is more sensitive for identifying pain in
mice that would otherwise be considered normal using the
welfare scoring system (i.e. that score <3/50). Notably, 24
mice that scored zero on the welfare assessment registered
a score on the MGS. One way to determine whether this
represents previously unrecognized ‘real’ pain is to look
for an improvement in response to analgesia.
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Figure 2. Comparison between standard welfare scoring and
average Mouse Grimace Scale (MGS) for all surgically
prepared mice (n = 46)
Effect of analgesia on pain score
Mice were compared before and 30 min after admin-
istration of buprenorphine, which was given regardless
of clinical need. Analysis of all mice showed a significant
improvement in scores regardless of the assessment
system. The average welfare score decreased by 33%
(Fig. 3Aa) and the average MGS score by 40% (P= 0.003;
Fig. 3Ba). Subgroup analysis showed that this was driven
mainly by improvements in mice that were deemed to be
‘in pain’ prior to analgesia (Fig. 3Ab and Bb). Mice ‘not in
pain’ did not show any benefit from analgesia when scored
using the welfare system (Fig. 3Ac), but the same mice
improved significantly when assessed by MGS (average
decrease of 48%, P = 0.04; Fig. 3Bc). This suggests that
the low-level pain detected by this type of MGS is real,
because it is treatable by analgesia. More typically, the
MGS would be scored by a single observer in real time as
an on-the-spot pain assessment tool, and to simulate these
conditions we re-analysed our data using the mode of the
observers’ scores. In these conditions, an improvement
was observed only in mice that were previously identified
as ‘in pain’ (Fig. 3Ca and Cb), and the technique was not
sensitive enough to identify an improvement in the ‘not
in pain’ group (Fig. 3Cc).
Effect of infarct size on pain score
To determine whether myocardial infarction contributed
to pain experienced at 24 h postsurgery, we stratified
mice according to MRI-derived infarct size. In addition,
we included a ‘death’ group (n = 7), which included
mice that survived surgery but which subsequently died
before infarct size could be measured at the end of the
study. This group consisted of two mice that were killed
24 h after surgery (continued poor welfare scoring after
buprenorphine dosing triggered our humane end-point),
one that died of cardiac rupture at day 4, and the others
that died due to heart failure at days 3, 22, 49 and 52
after surgery. All stock control mice (no surgery) had very
low MGS scores (mean 0.06 ± 0.06), indicating a low
level of false positives. Exposure to general anaesthesia
increased variability, but did not significantly alter MGS
(GA group mean, 0.11 ± 0.10). In sham mice (which
underwent thoracotomy only) and in mice with infarct
size (IS)<40%, the pain levels measured by theMGSwere
very similar (0.5 ± 0.5 in sham, 0.5 ± 0.4 for IS <25%,
and 0.5 ± 0.4 for IS 25–40%). However, in mice with very
large infarcts (IS >40%), the average MGS scores were
higher (1.7 ± 1.5) and even higher in those mice that
would go on to die before the end of the 8 week protocol
(4.6 ± 1.8; Fig. 4A). When the same mice were assessed
using the welfare score criteria, all but one of the infarcted
mice with IS <40% (n = 28) had a welfare score <3 and
C© 2014 The Authors. Experimental Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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would therefore be considered as ‘not in pain’ according
to traditional criteria (Fig. 4B).
Discussion
The main finding of this study is that detailed post hoc
analysis of the Mouse Grimace Scale is a sensitive tool for
the assessment of complex postsurgical pain. Using this
system,wedemonstrated that a significant number ofmice
are in low-level pain 24 h after thoracotomy and would
benefit from further analgesia. These mice could not be
identified using traditional welfare scoring methods, nor
by MGS when applied as an on-the-spot pain assessment
tool.Most of this pain is associatedwith thoracotomy,with
pain from myocardial infarction only contributing when
infarct size is particularly large (>40%).
For pain assessment, we scored the intensity of five
facial expressions as described by Langford et al. (2010)
from 10 high-quality photographs for each mouse. This
was performed blind by two independent observers,
who received no formal training and scored purely on
the basis of the information contained in the MGS
Aa
40 Difference
pre versus post
Difference
pre versus post
Difference
pre versus post
Difference
pre versus post
Difference
pre versus post
Difference
pre versus post
Difference
pre versus post
Difference
pre versus post
Difference
pre versus post
All mice Mice ‘in pain’ Mice not ‘in pain’
Mice ‘in pain’ Mice not ‘in pain’
Mice ‘in pain’ Mice not ‘in pain’
All mice
All mice
**
**
**
*
*
*
*
30
20
10
0
Pre Post
Pre Post
Pre Post
Pre Post
Pre Post
Pre Post
Pre Post
Pre Post
Pre Post
W
el
fa
re
 s
co
re
Ab
40
30
20
10
0
W
el
fa
re
 s
co
re
Ac
3
n.s.
n.s.
2
1
0
W
el
fa
re
 s
co
re
Bc
4
3
2
2
2
2
2
1
0
A
ve
ra
ge
M
G
S
 s
co
re
Bb
10
8
6
4
2
0
A
ve
ra
ge
M
G
S
 s
co
re
Ba
10
8
6
4
2
0
A
ve
ra
ge
M
G
S
 s
co
re
Ca
10
8
6
4
2
0
M
od
e
M
G
S
 s
co
re
Cb
10
8
6
4
2
0
M
od
e
M
G
S
 s
co
re
Cc
6
4
4
4
3
3
2
0
M
od
e
M
G
S
 s
co
re
Figure 3. Effect of buprenorphine analgesia on pain assessed at 24 h postsurgery
Assessments were made before and 30 min after S.C. injection using the following three methods: a
welfare scoring sheet (Aa, Ab and Ac); the average MGS score of two blinded observers (Ba, Bb and
Bc); and the mode of the MGS score to represent a single ‘on-the-spot’ examination (Ca, Cb and Cc).
All scoring systems identified a significant improvement following administration of analgesia when all
mice (n = 13) were analysed together (Aa, Ba and Ca) or when only mice readily identifiable as ‘in pain’
were included (n = 7), i.e. welfare score 3 (Ab, Bb and Cb). However, only the average MGS method
detected an improvement in mice that were otherwise not considered in pain (n = 6), i.e. welfare score
<3 (Ac, Bc and Cc). All data were analysed using aWilcoxon matched pairs signed rank test. ‘n.s.’ denotes
non-significant; ∗P < 0.05 and ∗∗P < 0.01. For all graphs, the single points represent single mice, unless
otherwise stated. The bars are means ± 95% confidence intervals.
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manual (provided on request by Dr Jeffrey Mogil, McGill
University, Montreal, QC, Canada). The correlation of
scores between observers was good, but with a slight
systematic bias. This suggests that the facial changes
induced by pain are easily detected even by novice
observers, but that interpretation of intensity is more
subjective. Ideally, MGS scoring should therefore be
performed by the same observer if subtle changes in pain
levels are to be assessed serially in the same animal.
It is important to note that we used the mean score
of both observers for most of our analyses. In this way,
we obtained non-integer scores on what is normally
a whole number scale. This proved to be particularly
sensitive, because we observed a significant proportion
of mice scoring on the MGS but not on the welfare-based
system.This raises thepossibility that a large subset ofmice
were experiencing low-level pain, which is missed when
using standard assessmentmethods. The fact that theMGS
score improved in these mice following administration
of an extra dose of buprenorphine strongly suggests that
this pain is real and not simply an artefact or caused by
noise in our analysis system. Although this decrease is
moderate in absolute value (0.7 points on a scale of 10),
it represents a reduction by half of the average MGS score
following administration of buprenorphine and is likely to
be physiologically relevant. Therefore, MGS proved to be
very sensitive in detecting pain in a mouse population,
but the technique originally described remains labour
intensive, with scoring of 10 individual photographs,
hence unpractical at the ‘bedside’. Although MGS has
been suggested as a quick and easy method for assessing
postsurgical pain in individualmice (e.g. Leach et al.2012),
this has not been extensively studied and to simulate this,
we re-analysed our data to report the mode score of the
observers (i.e. a whole number scale). It is notable that in
this format the MGS could clearly identify improvements
in animals that had clinical manifestations of pain, but
was not sensitive enough to detect improvements in the
low-level pain group. This suggests that on-the-spot MGS
observations are not any better than standard welfare
scoring sheets for identifying mice with postoperative
pain. In contrast, blinded, multi-observer, post hoc MGS
analysis provides greater sensitivity and represents a useful
tool for assessing analgesic protocols in a population of
mice. This study has led to a change in our practice, and
wenowgive a seconddose of postoperative buprenorphine
to all mice as standard.
Previous studies have compared MGS with automated
behavioural analysis and found that it was better at
detecting the effect of postoperative analgesia (Leach et al.
2012). One explanation is that MGS is thought to reflect
an integrated response to pain, with an associated affective
component (Langford et al. 2010; Leach et al. 2012). The
other consideration is that mice are prey animals and will
therefore adapt to pain to prevent appearing vulnerable
to predators. For this reason, behavioural changes are
mainly observed with acute surgical pain (hours) but are
less pronounced in longer-lasting pain (days; Roughan
& Flecknell, 2001; Mogil et al. 2010; Urban et al. 2011;
Matsumiya et al.2012).This represents themain limitation
A B
A
ve
ra
ge
 M
G
S
 s
co
re
10
8
6
4
2
0
W
el
fa
re
 S
co
re
40
*
**
**
*
*
**
***
***
30
20
10
4
2
3
1
0
St
oc
k m
ice
GA
 o
nly
Sh
am
IS
 <
 2
5%
25
%
 <
 IS
 <
 4
0%
IS
 >
 4
0%
De
at
h
Sh
am
IS
 <
 2
5%
25
%
 <
 IS
 <
 4
0%
IS
 >
 4
0%
De
at
h
Figure 4. Contribution of myocardial infarct size (IS) to pain assessment by traditional welfare score (A)
and average Mouse Grimace Scale (MGS) at 24 h postsurgery (B)
‘Death’ includes all mice that died or were killed before infarct size could be measured. By definition,
infarct size is likely to be large in these mice. ‘GA’ denotes mice that received isoflurane general
anesthesia but not surgery. Data were analysed using a Kruskal–Wallis test, with Dunn’s post hoc test;
∗P < 0.05, ∗∗P < 0.01 and ∗∗∗P < 0.001. Stock mice, n = 6; GA only, n = 8; sham, n = 5; IS <25%, n = 17;
25% < IS < 40%, n = 7; IS > 40%, n = 10; and death, n = 7. The bars are means ± SEM.
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of behavioural-based methods. However, Langford et al.
(2010) showed that this can also be a limitation for MGS,
where noxious stimuli of moderate duration (10 min to
4 h) gave high MGS score, whereas pain lasting hours to
days was undetected.
Effect of infarct size on pain score
Pain score levels were the same in sham mice (that
underwent thoracotomy only) and in mice with small to
moderate infarct sizes. This implies that the main source
of pain 24 h following the MI procedure is from the
thoracotomy rather than pain directly related to ligation
of the coronary artery. Death during the postsurgical
follow-up period was predominantly due to heart failure
or cardiac rupture, which are highly dependent on infarct
size (Lygate, 2006). It is therefore a reasonable assumption
that infarct size was particularly large in these mice.
These mice, together with mice that had large infarcts
(>40%) had very high MGS values, but differences were
less pronounced on the welfare scoring system. As the
clinical symptomsofheart failure (e.g. changes inmobility,
grooming and respiration) are more likely to be reflected
in the welfare scoring system, this suggests that very large
infarctsmay be associatedwith pain,which persists at 24 h.
Choice of analgesia protocol
Buprenorphine is the most frequently used analgesic to
treat postoperative pain in research laboratories in the
UK (Hawkins, 2002) owing to its high efficacy, mild
side-effects and relatively long duration of action (Karas,
2006; Matsumiya et al. 2012). The dose of buprenorphine
is extremely variable between laboratories, and the
0.6 mg kg−1 dose used in our study at 24 h is relatively
high (Wolfensohn & Lloyd, 2003; Matsumiya et al. 2012).
Although higher levels can be tolerated (Gades et al. 2000),
it seems unlikely that underdosing explains why MGS
scores did not reduce to control levels. It seems more
likely that the efficacy of buprenorphine was submaximal
at the time of re-assessment 30min postdosing, despite the
fact that pharmacokinetic studies show a very fast onset of
action following S.C. administration (Cowan et al. 1977).
Limitations
To assess the ability of MGS to screen for individual
animals as being in pain, the mode of multiple scores
was used to represent a single on-the-spot ‘bedside’
examination. Although this is only a proxy for real-time
MGS assessment, it was considered the best way to obtain
an unbiased single MGS score, because a true ‘bedside’
scoring system would have been unduly influenced by
general mouse behaviour and condition.
Although a statistically significant improvement was
observed in the average MGS of mice ‘not in pain’
following administration of buprenorphine, the number
of animals assessed was low, and replication on a larger
populationwouldallowbetter generalizationof the results.
Conclusion
In conclusion, post hoc analysis of MGS by multiple
blinded observers was used to assess pain following
thoracotomy and myocardial infarction. Our findings
suggest that a significant subset of mice were in low-level
pain at 24 h postsurgery that was undetectable by
standard welfare scoring methods or on-the-spot MGS
assessment. These findings are likely to be applicable to
all other surgeries requiring thoracotomy, e.g. cardiac
ischaemia–reperfusion or transverse aortic constriction,
and we now routinely provide a second dose of analgesic
to all mice. Furthermore, this experimental approach
represents a template for the assessment of analgesic
protocol efficacy in other complex postsurgical models,
thereby contributing to the advancement of the ‘3Rs’.
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